Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7907987rdf:typepubmed:Citationlld:pubmed
pubmed-article:7907987lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:7907987lifeskim:mentionsumls-concept:C0439855lld:lifeskim
pubmed-article:7907987lifeskim:mentionsumls-concept:C0598695lld:lifeskim
pubmed-article:7907987lifeskim:mentionsumls-concept:C1709059lld:lifeskim
pubmed-article:7907987pubmed:issue1lld:pubmed
pubmed-article:7907987pubmed:dateCreated1994-4-25lld:pubmed
pubmed-article:7907987pubmed:abstractText7-Chlorokynurenate, an antagonist at the glycine recognition site of the NMDA receptor complex, increases the binding of the competitive NMDA receptor antagonist [3H]CGP39653 ([3H]D,L-(E)-2-amino-4-propyl-5-phosphono-3-pentenoic acid) to well washed rat brain membranes but only in the presence of 100 microM spermine. Conversely, spermine only increases [3H]CGP39653 binding in the presence of 10 microM 7-chlorokynurenate, through a mechanism insensitive to the putative polyamine antagonists ifenprodil, arcaine or putrescine. Thus, the effects of glycine antagonists and polyamines on the binding of competitive NMDA receptor antagonists may depend on the residual glycine and polyamine content of the membrane preparation or the state of the glycine recognition site. These data further attest to the complexity of interactions between spermine and the glycine and glutamate recognition sites of the NMDA receptor.lld:pubmed
pubmed-article:7907987pubmed:languageenglld:pubmed
pubmed-article:7907987pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7907987pubmed:citationSubsetIMlld:pubmed
pubmed-article:7907987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7907987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7907987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7907987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7907987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7907987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7907987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7907987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7907987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7907987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7907987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7907987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7907987pubmed:statusMEDLINElld:pubmed
pubmed-article:7907987pubmed:monthJanlld:pubmed
pubmed-article:7907987pubmed:issn0014-2999lld:pubmed
pubmed-article:7907987pubmed:authorpubmed-author:OblinAAlld:pubmed
pubmed-article:7907987pubmed:authorpubmed-author:SchoemakerHHlld:pubmed
pubmed-article:7907987pubmed:issnTypePrintlld:pubmed
pubmed-article:7907987pubmed:day1lld:pubmed
pubmed-article:7907987pubmed:volume266lld:pubmed
pubmed-article:7907987pubmed:ownerNLMlld:pubmed
pubmed-article:7907987pubmed:authorsCompleteYlld:pubmed
pubmed-article:7907987pubmed:pagination103-6lld:pubmed
pubmed-article:7907987pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7907987pubmed:meshHeadingpubmed-meshheading:7907987-...lld:pubmed
pubmed-article:7907987pubmed:meshHeadingpubmed-meshheading:7907987-...lld:pubmed
pubmed-article:7907987pubmed:meshHeadingpubmed-meshheading:7907987-...lld:pubmed
pubmed-article:7907987pubmed:meshHeadingpubmed-meshheading:7907987-...lld:pubmed
pubmed-article:7907987pubmed:meshHeadingpubmed-meshheading:7907987-...lld:pubmed
pubmed-article:7907987pubmed:meshHeadingpubmed-meshheading:7907987-...lld:pubmed
pubmed-article:7907987pubmed:meshHeadingpubmed-meshheading:7907987-...lld:pubmed
pubmed-article:7907987pubmed:meshHeadingpubmed-meshheading:7907987-...lld:pubmed
pubmed-article:7907987pubmed:meshHeadingpubmed-meshheading:7907987-...lld:pubmed
pubmed-article:7907987pubmed:meshHeadingpubmed-meshheading:7907987-...lld:pubmed
pubmed-article:7907987pubmed:meshHeadingpubmed-meshheading:7907987-...lld:pubmed
pubmed-article:7907987pubmed:meshHeadingpubmed-meshheading:7907987-...lld:pubmed
pubmed-article:7907987pubmed:meshHeadingpubmed-meshheading:7907987-...lld:pubmed
pubmed-article:7907987pubmed:meshHeadingpubmed-meshheading:7907987-...lld:pubmed
pubmed-article:7907987pubmed:meshHeadingpubmed-meshheading:7907987-...lld:pubmed
pubmed-article:7907987pubmed:meshHeadingpubmed-meshheading:7907987-...lld:pubmed
pubmed-article:7907987pubmed:year1994lld:pubmed
pubmed-article:7907987pubmed:articleTitleComplex allosteric modulation of the binding of the NMDA receptor antagonist [3H]CGP39653.lld:pubmed
pubmed-article:7907987pubmed:affiliationDepartment of Preclinical Research, Synthélabo Recherche (L.E.R.S.), Bagneux, France.lld:pubmed
pubmed-article:7907987pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7907987pubmed:publicationTypeIn Vitrolld:pubmed